Emergent BioSolutions Inc.EBSNYSE
Loading
Revenue ContractionContracting
Percentile Rank50
3Y CAGR-12.7%
5Y CAGR-14.0%
Year-over-Year Change
Total revenue from sales of goods and services
3Y CAGR
-12.7%/yr
vs +9.3%/yr prior
5Y CAGR
-14.0%/yr
Consistent
Acceleration
-22.0pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
4 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $742.90M | -28.8% |
| 2024 | $1.04B | -0.5% |
| 2023 | $1.05B | -6.1% |
| 2022 | $1.12B | -37.0% |
| 2021 | $1.77B | +12.4% |
| 2020 | $1.58B | +42.6% |
| 2019 | $1.11B | +41.4% |
| 2018 | $782.40M | +39.5% |
| 2017 | $560.90M | +14.8% |
| 2016 | $488.80M | - |